5 Cheap Biotech Stocks Smart Investors Are Piling Into

Page 5 of 5

1. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Number of Hedge Fund Investors In Q2 2023: 56

P/E Ratio: 22.27

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a large biotechnology company that develops treatments for diabetes, eye diseases, cancer, and other diseases. The firm expanded its research and development portfolio in August as it enlarged its partnership with a gene editing firm to develop treatments for muscular problems.

Insider Monkey’s Q2 2023 survey covering 910 hedge funds revealed that 56 had held a stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Out of these, John Overdeck and David Siegel’s Two Sigma Advisors holds the largest stake that comes via 229,300 shares and is worth $216 million.

Follow Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Disclosure: None. You can also take a look at Top 15 Cloud Computing Companies in the World and 11 Most Undervalued Biotech Stocks to Buy According to Analysts.

Follow Insider Monkey on Twitter

Page 5 of 5